Education
About Us
Working with TipRanks
Follow Us
CSL (AU:CSL)
ASX:CSL
CSL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$228.61 - AU$313.55
Previous CloseN/A
Volume375.76K
Average Volume (3M)879.20K
Market Cap
$124.16B
Enterprise ValueAU$156.94B
Total Cash (Recent Filing)$728.82M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)29.8
Beta0.48
Next Earnings
Aug 19, 2025EPS Estimate
3.51Last Dividend Ex-Date
Mar 10, 2025Dividend Yield1.78%
Share Statistics
EPS (TTM)6.65
Shares Outstanding484,212,130
10 Day Avg. Volume726,392
30 Day Avg. Volume879,195
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit20.76
Enterprise Value/Ebitda16.46
Forecast
1Y Price Target
$314.87Price Target Upside22.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
---
CSL News
PremiumCompany Announcements
CSL Limited Announces Cessation of Securities
PremiumCompany Announcements
CSL Monitors U.S. Tariff Developments to Safeguard Medicine Access
PremiumCompany Announcements
CSL Limited Announces Director’s Share Acquisition
PremiumCompany Announcements
CSL Limited Announces Cessation of Securities
PremiumCompany Announcements
CSL Limited Updates Dividend Distribution Details
PremiumCompany Announcements
CSL Limited Issues Unquoted Equity Securities Under Employee Incentive Scheme
PremiumCompany Announcements
CSL Limited Announces Quotation of New Securities on ASX---
Options Prices
Currently, No data available
---
Ownership Overview
0.05% Insiders
5.04%
Mutual Funds
<0.01% Other Institutional Investors
87.12% Public Companies and
Individual Investors
CSL FAQ
What was CSL’s price range in the past 12 months?
CSL lowest share price was AU$228.61 and its highest was AU$313.55 in the past 12 months.
What is CSL’s market cap?
CSL’s market cap is $124.16B.
When is CSL’s upcoming earnings report date?
CSL’s upcoming earnings report date is Aug 19, 2025 which is in 105 days.
How were CSL’s earnings last quarter?
CSL released its earnings results on Feb 11, 2025. The company reported AU$6.654 earnings per share for the quarter, missing the consensus estimate of AU$6.846 by -AU$0.192.
Is CSL overvalued?
According to Wall Street analysts CSL’s price is currently Undervalued.
Does CSL pay dividends?
CSL pays a Annually dividend of AU$2.071 which represents an annual dividend yield of 1.78%. See more information on CSL dividends here
What is CSL’s EPS estimate?
CSL’s EPS estimate is 3.51.
How many shares outstanding does CSL have?
CSL has 484,212,130 shares outstanding.
What happened to CSL’s price movement after its last earnings report?
CSL reported an EPS of AU$6.654 in its last earnings report, missing expectations of AU$6.846. Following the earnings report the stock price went down -0.265%.
Which hedge fund is a major shareholder of CSL?
Currently, no hedge funds are holding shares in AU:CSL
---
CSL Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$314.87 (22.80% Upside)
$314.87 (22.80% Upside)
Blogger Sentiment
Bullish
AU:CSL Sentiment 72%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $32.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.72%
12-Months-Change
Fundamentals
Return on Equity
15.38%
Trailing 12-Months
Asset Growth
3.06%
Trailing 12-Months
Company Description
CSL
CSL Limited is a global biotechnology company that specializes in the development, manufacturing, and marketing of innovative biotherapies and influenza vaccines. The company operates primarily in two segments: CSL Behring, which focuses on protein-based therapies for rare and serious conditions, and Seqirus, one of the world's largest influenza vaccine providers. CSL's core products include treatments for hemophilia, immunodeficiency disorders, and hereditary angioedema, alongside a broad portfolio of influenza vaccines.
---
CSL Company Deck
---
CSL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive sentiment, with strong financial performance led by CSL Behring and a promising outlook despite challenges in CSL Seqirus and specialty products due to external market conditions.Read More>---
CSL Stock 12 Month Forecast
Average Price Target
AU$314.87
▲(22.80% Upside)
Technical Analysis
Ramsay Health Care
―
Cochlear
―
Ansell
―
Sonic Healthcare Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
---